SLIMAMP
Live / Registered — Registered and renewed (as of 11 Jun 2026)
What this means for you
Registered since 07 Jun 2016. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 07 Jun 2036: the §8 & §9 renewal).
Record
- Serial number
- 86620439
- Registration number
- 4974703
- Mark type
- Word mark
- Filed
- 05 May 2015
- Published for opposition
- 24 Nov 2015
- Registered
- 07 Jun 2016
- Current term from
- 07 Jun 2026
- Next maintenance filing
- §8 & §9 renewal, due by 07 Jun 2036 (grace period to 07 Dec 2036)
- Attorney of record
- Viola T. Kung
Goods and services
- Class 001 — Chemicals: Reagents and reagent kits comprising nucleic acids, naturally occurring and modified nucleotides, enzymes, labels, and buffers, all for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, regulation, transcription, and expression in the fields of scientific research, clinical research, and scientific diagnostics research; Biological and biochemical reagents used for selectively amplifying nucleic acid fragments for scientific research, clinical research, and scientific diagnostics research
- Class 005 — Pharmaceuticals: Reagents and reagent kits comprising nucleic acids, naturally occurring and modified nucleotides, enzymes, labels, and buffers, all for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, regulation, transcription, and expression, with the aforementioned reagents and reagent kits being for medical diagnostic purposes; Biological and biochemical reagents used for selectively amplifying nucleic acid fragments, with the aforementioned reagents being used for medical diagnostic purposes; Biological and biochemical kits comprised of diagnostic preparations for medical purposes, namely, for the diagnosis and treatment of cancer
Owner
- Pillar Biosciences, Inc., Natick, MA, US
- Pillar Biosciences, Inc., Natick, MA, US
- Pillar Biosciences, Inc., Natick, MA, US
Prosecution history
- 11 Jun 2026 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 11 Jun 2026 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 11 Jun 2026 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 01 Jun 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 30 Mar 2026 — TEAS SECTION 8 & 9 RECEIVED
- 08 Jun 2025 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 30 Sept 2021 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 30 Sept 2021 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 30 Sept 2021 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 17 Jun 2021 — TEAS SECTION 8 & 15 RECEIVED
- 07 Jun 2021 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 07 Jun 2016 — REGISTERED-PRINCIPAL REGISTER
- 05 May 2016 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 04 May 2016 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 26 Apr 2016 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED